Suppr超能文献

[1例乳腺癌肝内动脉化疗后可切除肝转移瘤]

[A case resectable hepatic metastases of breast cancer following intrahepatic arterial chemotherapy].

作者信息

Matsumoto J, Minami T, Takami M, Takanishi K, Matsumine T

机构信息

Dept. of Surgery, Tokyo Metropolitan Fuchu Hospital.

出版信息

Gan To Kagaku Ryoho. 1996 Sep;23(11):1542-5.

PMID:8854801
Abstract

A 38-year-old woman who had undergone Patey's operation for left breast cancer in July 1990 was admitted in December 1992 for hepatic metastases. Due to bone metastasis (Th10), oophorectomy and hepatic arterial cannulation were performed. Hepatic arterial chemotherapy and oral chemoendocrine therapy yielded a partial response for liver and unclear metastasis of the bone. She had arterial and oral administration after a hepatectomy in October 1994. The patient has had no recurrent signs now (July 1996). We experienced 522 patients with breast carcinoma and 14 cases (2.7%) of all having hepatic metastases. Hepatic arterial chemotherapy was done in three patients. Although one of them had a complete response, she died after 35 months because of bone, brain and liver metastases. Another case was underwent hepatectomy after arterial chemotherapy, but recurrent liver and bone tumors soon appeared. The mean survival period of 15 hepatic metastases, including the case under study here was 9 months, and the one-year survival rate was 23.4%.

摘要

一名38岁女性于1990年7月因左乳腺癌接受了帕蒂手术,1992年12月因肝转移入院。由于骨转移(胸10),进行了卵巢切除术和肝动脉插管术。肝动脉化疗和口服化学内分泌治疗使肝脏和不明骨转移灶出现部分缓解。1994年10月她接受肝切除术后进行了动脉和口服给药。该患者目前(1996年7月)无复发迹象。我们共诊治了522例乳腺癌患者,其中14例(2.7%)发生肝转移。3例患者接受了肝动脉化疗。其中1例完全缓解,但35个月后因骨、脑和肝转移死亡。另一例在动脉化疗后接受了肝切除术,但很快出现肝脏和骨肿瘤复发。包括本研究病例在内的15例肝转移患者的平均生存期为9个月,1年生存率为23.4%。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验